Table 1

Baseline demographics of the study population

ParametersPatients with bronchiectasis
N=34
Healthy volunteers
N=6
Mild
n=10
Moderate
n=15
Severe
n=9
Age (years)55 (4.1)65 (2.2)64 (2.2)52 (6.8)
Biological sex (% female)40602280
Aetiology
 Idiopathic10 (100%)12 (80%)6 (67%)
 Postinfective3 (20%)3 (33%)
Total WCC (×109/L)6 (0.5)6.3 (0.4)9.3 (1.1)5.9 (0.5)
Neutrophils3.3 (0.3)4.1 (0.3)6.6 (1.1)3.5 (0.3)
Eosinophils0.2 (0.04)0.3 (0.07)0.2 (0.06)0.2 (0.06)
Monocytes0.5 (0.03)0.6 (0.05)0.7 (1)0.5 (0.05)
ESR (mm/hour)6.7 (1.8)13.2 (2.9)19.6 (6.8)4.8 (1)
CRP (mg/L)2.8 (0.5)4 (1)16 (7.4)3.2 (1.1)
FEV1 % predicted (L)95 (5.5)82 (4)55 (6.5)
FVC % predicted (L)111 (6)97 (4)84 (6)
TLCO % predicted (SI)94% (4.9)82% (4.2.)74% (7.8)
KCO % predicted (SI)106% (4.5)97% (3.7)100% (7.2)
Chronic colonisation5 (50%)12 (86%)8 (89%)
Exacerbations in the last year0.4 (0.3)2.4 (0.5)4.2 (0.9)
Hospital admissions in the last year00.05 (0.05)0.7 (0.2)
  • Data presented as mean (±SE of mean).

  • CRP, C reactive protein; ESR, erythrocyte sedimentation rate; FEV1, forced expiratory volume in 1 s; FVC, forced vital capacity; KCO, transfer coefficient corrected for alveolar volume; TLCO, transfer factor for the lung for carbon monoxide; WCC, white cell count.